- Home
- LXEO vs POET Comparison
LXEO vs POET Comparison
Compare LXEO & POET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXEO
- POET
- Stock Information
- Founded
- LXEO 2017
- POET 1972
- Country
- LXEO United States
- POET Canada
- Employees
- LXEO N/A
- POET N/A
- Industry
- LXEO
- POET Semiconductors
- Sector
- LXEO
- POET Technology
- Exchange
- LXEO Nasdaq
- POET Nasdaq
- Market Cap
- LXEO 597.8M
- POET 550.2M
- IPO Year
- LXEO 2023
- POET N/A
- Fundamental
- Price
- LXEO $9.34
- POET $4.16
- Analyst Decision
- LXEO Strong Buy
- POET Strong Buy
- Analyst Count
- LXEO 8
- POET 2
- Target Price
- LXEO $18.13
- POET $6.25
- AVG Volume (30 Days)
- LXEO 1.4M
- POET 12.7M
- Earning Date
- LXEO 11-05-2025
- POET 11-13-2025
- Dividend Yield
- LXEO N/A
- POET N/A
- EPS Growth
- LXEO N/A
- POET N/A
- EPS
- LXEO N/A
- POET N/A
- Revenue
- LXEO N/A
- POET $762,695.00
- Revenue This Year
- LXEO N/A
- POET $3,433.93
- Revenue Next Year
- LXEO N/A
- POET $596.72
- P/E Ratio
- LXEO N/A
- POET N/A
- Revenue Growth
- LXEO N/A
- POET 535.87
- 52 Week Low
- LXEO $1.45
- POET $3.09
- 52 Week High
- LXEO $10.38
- POET $9.41
- Technical
- Relative Strength Index (RSI)
- LXEO 58.98
- POET 29.59
- Support Level
- LXEO $7.66
- POET $4.97
- Resistance Level
- LXEO $9.63
- POET $5.74
- Average True Range (ATR)
- LXEO 0.64
- POET 0.50
- MACD
- LXEO -0.08
- POET -0.25
- Stochastic Oscillator
- LXEO 64.71
- POET 1.72
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.
About POET POET Technologies Inc.
POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The company operates geographically in the United States, Canada, Singapore and China.